Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 … – Business Wire

SAN MATEO, Calif.–(BUSINESS WIRE)–Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver …

  • You already voted!
  • Read More